Search research articles
Contact Us
Filters
Showing results (761-770 of 827) with videos related to
Page
of 83
Sort By:
Frontiers in Chemical Biology
|
April 20, 2026
Development of SYK NanoBRET cellular target engagement assays for gain-of-function variants
Jacob L Capener, James D Vasta, Vittorio L Katis, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Development of SYK NanoBRET Cellular Target Engagement Assays for Gain-of-Function Variants
Jacob L Capener, James D Vasta, Vittorio L Katis, et al.
Physical Review Letters
|
March 13, 2026
Detailed View at Magnetic Dipole Strengths: The Case of Semimagic ^{50}Ti
B Kelly, M Spieker, U Friman-Gayer, et al.
Steroids
|
June 15, 2014
Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle
Fan Ye, Sean C McCoy, Heather H Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2014
Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy
Cristina Saura, Johanna Bendell, Guy Jerusalem, et al.
Breast (Edinburgh, Scotland)
|
June 24, 2016
Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study
G Curigliano, P Gómez Pardo, F Meric-Bernstam, et al.
Geroscience
|
December 17, 2025
Beyond strength: dietary nitrate augments self-selected functional mobility after resistance training in middle-aged adults
Brandon M Peoples, Mason C McIntosh, Kenneth D Harrison, et al.
Cell Chemical Biology
|
July 25, 2023
DELs enable the development of BRET probes for target engagement studies in cells
Kelly A Teske, Wenji Su, Cesear R Corona, et al.
ESMO Open
|
June 28, 2023
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial
J Rodon Ahnert, D S-W Tan, I Garrido-Laguna, et al.
Physical Review Letters
|
June 10, 2017
E2 decay strength of the M1 scissors mode of ^{156}Gd and its first excited rotational state
T Beck, J Beller, N Pietralla, et al.
Page
of 83
Search research articles
Search
Showing results (761-770 of 827) with videos related to
Sort By:
Page
of 83
Frontiers in Chemical Biology
|
April 20, 2026
Development of SYK NanoBRET cellular target engagement assays for gain-of-function variants
Jacob L Capener, James D Vasta, Vittorio L Katis, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Development of SYK NanoBRET Cellular Target Engagement Assays for Gain-of-Function Variants
Jacob L Capener, James D Vasta, Vittorio L Katis, et al.
Physical Review Letters
|
March 13, 2026
Detailed View at Magnetic Dipole Strengths: The Case of Semimagic ^{50}Ti
B Kelly, M Spieker, U Friman-Gayer, et al.
Steroids
|
June 15, 2014
Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle
Fan Ye, Sean C McCoy, Heather H Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2014
Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy
Cristina Saura, Johanna Bendell, Guy Jerusalem, et al.
Breast (Edinburgh, Scotland)
|
June 24, 2016
Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study
G Curigliano, P Gómez Pardo, F Meric-Bernstam, et al.
Geroscience
|
December 17, 2025
Beyond strength: dietary nitrate augments self-selected functional mobility after resistance training in middle-aged adults
Brandon M Peoples, Mason C McIntosh, Kenneth D Harrison, et al.
Cell Chemical Biology
|
July 25, 2023
DELs enable the development of BRET probes for target engagement studies in cells
Kelly A Teske, Wenji Su, Cesear R Corona, et al.
ESMO Open
|
June 28, 2023
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial
J Rodon Ahnert, D S-W Tan, I Garrido-Laguna, et al.
Physical Review Letters
|
June 10, 2017
E2 decay strength of the M1 scissors mode of ^{156}Gd and its first excited rotational state
T Beck, J Beller, N Pietralla, et al.
Page
of 83